-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
FWM-4
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2757194-03-7.gif)
| Category | SARS-CoV |
| CAS | 2757194-03-7 |
| Description | FWM-4 is a potent SARS-COV-2 NSP13 helicase enzyme inhibitor. |
Product Information
| Synonyms | FWM-4|ZINC16292141|AKOS024362437|HY-144799|CS-0434620 |
| Molecular Weight | 426.42 |
| Molecular Formula | C24H18N4O4 |
| Canonical SMILES | CC1=CC=C(C=C1)C(C2=C(C3=C(NC2=O)N=CC=C3)O)C4=C(C5=C(NC4=O)N=CC=C5)O |
| Purity | ≥98% |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -22 C for long term (months to years). |
| Complexity | 787 |
| Exact Mass | 426.13280507 |
| Target | SARS-CoV |
| XLogP3-AA | 1.8 |
